-
1 month ago | 
universityofcalifornia.edu | Laura Gonzalez |Laura González
It was the late 1960s, and new Department of Medicine Chair Lloyd Hollingsworth “Holly” Smith Jr., M.D., was set on turning UC San Francisco into a basic science research powerhouse. It was a move bolstered by a rise in National Institutes of Health (NIH) funding for science across the board. He hired biochemist William J. Rutter, Ph.D., to resuscitate the Biochemistry and Biophysics Department.
-
Mar 14, 2025 | 
medicalxpress.com | Laura Gonzalez |Laura González
Consumption, phthisis, the white plague—a killer by any other name, tuberculosis (TB) has stalked humanity since at least the ice age. Today, the disease—passed from those who are actively sick to others through airborne droplets—is the leading infectious disease killer globally. Still, for decades, the fight against TB has been frozen in time, even as the bacteria that causes it has become more resistant.
-
Mar 13, 2025 | 
universityofcalifornia.edu | Payam Nahid |Adithya Cattamanchi |Laura Gonzalez |Laura González
And a quicker cure is a more effective cure, explains UCSF’s Institute for Global Health Sciences Executive Director Payam Nahid, MD, MPH. “People are more likely to finish shorter treatment courses, which makes them more effective and guards against the development of drug resistance,” he says.
-
Feb 14, 2025 | 
medicalxpress.com | Laura Gonzalez |Laura González
You're reaching for your keys in the parking lot after a doctor's visit when it hits you, "What did my physician say I wasn't supposed to take with this new medication?" Visits can feel like a slalom for patients and providers. Patients can struggle to take in what feels like a mountain of medical information. Health care providers face their own challenges, from patient loads to paperwork.
-
Jan 30, 2025 | 
medicalxpress.com | Laura Gonzalez |Laura González
The U.S. will ban nearly all uses of the common industrial cleaning agent, trichloroethylene (TCE), this year—more than 50 years after it led to one of the country's worst cases of contaminated drinking water. It has been found in up to a third of sampled U.S. drinking water, including near Modesto, Fresno and Santa Rosa, California.
-
Nov 7, 2024 | 
medicalxpress.com | Laura Gonzalez |Laura González
UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at the university earlier this year. The treatment, known as E-SYNC, is a form of "switchable" CAR-T therapy that can be turned on and off to better target cancer and reduce side effects.
-
Oct 1, 2024 | 
medicalxpress.com | Laura Gonzalez |Laura González
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:Colorectal cancer cases are rising among younger people, striking even folks without obvious risk factors. For nearly two decades, UC San Francisco Family Community Medicine Professor Micheal Potter, MD, has worked to make cancer screening easier.
-
Aug 30, 2024 | 
spotlightnsp.co.za | Luvuyo Mehlwana |Amy Green |Biénne Huisman |Laura Gonzalez |Laura González
South Africa has some of the highest TB and DR-TB incidence rates in the world. (Photo: Canva rework by Spotlight) Comment & Analysis30th August 2024 | Fatima Hassan and Leena Menghaney A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa.
-
Jul 29, 2024 | 
spotlightnsp.co.za | Elsabe Brits |Tiyese Jeranji |Elri Voigt |Laura Gonzalez |Laura González
Long acting antiretroviral formulations approved in South Africa include an injection called CAB-LA and the dapivirine ring.(Pixabay rework by Spotlight) News & Features29th July 2024 | Elri Voigt Taking antiretrovirals to prevent HIV infection mostly still involves swallowing one or more pills a day. Some long-acting products that work for a month or two at a time have been approved but are not yet in wide use in South Africa.
-
Jul 26, 2024 | 
medicalxpress.com | Laura Gonzalez |Laura González
UC San Francisco scientists have found that SARS-CoV-2 can linger in the body for years and could be driving a global epidemic in long COVID. They're also exploring the surprising long-term risks of getting COVID in pregnancy. Assistant Professor of Medicine Michael Peluso, MD, heads UCSF's LIINC program, short for "Long-term Impact of Infection with Novel Coronavirus," a university-wide effort to understand one of COVID-19's most enduring challenges.
